PrimeLink

BiotechnologyAngelShenzhen, China

Latest round

Angel

Last raised

Nov 2022

Total raised

$14M

Investors

3

About PrimeLink

Established in 2021 and based in Shenzhen, China, PrimeLink operates as a drug developer that focuses on medical and health services, and drug delivery systems and antibody-coupled drugs (ADCs) R&D. The company's R&D center located in Suzhou industrial park. It has more than 20 employees and more than 50% of the core research team has doctor's degree. Dr. Yin is the founder of the company, and has nearly 20 years of ADC drug development experience, and was the core inventor of Mersana's first and second generation linker. The company provides ADC drug pool platform. It focuses on the establishing first in class & best in class product pipeline. ADC Drugs includes four components : antibodies, biocouples, connectors and payloads.

Who invested in PrimeLink

3 investors across 1 round

See all investors in PrimeLink

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Nov 25, 2022

    Amount

    $14M

    Investors

    Locked

Questions about PrimeLink

Who invested in PrimeLink?

PrimeLink has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has PrimeLink raised?

PrimeLink has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did PrimeLink last raise money?

PrimeLink's most recent round on record is a Angel, in Nov 2022.

What does PrimeLink do?

Established in 2021 and based in Shenzhen, China, PrimeLink operates as a drug developer that focuses on medical and health services, and drug delivery systems and antibody-coupled drugs (ADCs) R&D.

Where is PrimeLink headquartered?

PrimeLink is headquartered in Shenzhen, China.

Which VCs invest in companies like PrimeLink?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at PrimeLink's stage. Their profiles are linked below.

Raising like PrimeLink? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.